Buscar
Mostrando ítems 1-10 de 43
Comentario del artículo original: “ Vancomycin pharmacokinetic–pharmacodynamic parameters to optimize dosage administration in critically ill children”
(Facultad de Medicina. Hospital de Clínicas. Departamento de Farmacología y Terapeútica., 2012)
Dexmedetomidine metabolic clearance is not affected by fat mass in obese patients.
(2018)
Background: Obesity has been associated with reduced dexmedetomidine clearance, suggesting impaired hepatic
function or reduced hepatic blood flow. The aim of this study was to clarify the effect of obesity in dexmedetom ...